49
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Genotoxicity studies on HM10760A, recombinant human erythropoietin conjugated to globin fragment

, , , , , & show all
Pages 152-159 | Received 06 May 2009, Accepted 21 Jul 2009, Published online: 22 Mar 2010

References

  • Bohlius, J., Weingart, O., Trelle, S., Engert, A. (2006). ­Cancer-related anemia and recombinant human erythropoietin—an updated overview. Nat Clin Pract Oncol 3:152–164.
  • Che, J.-H., Li, G.-X., Park, J.-S., Yun, J.-W., Kim, T.-W., Kim, H.-S., et al. (1999). Mutagenicity test of erythropoietin (EPO). J Toxicol Pub Health 15:413–417.
  • Debeljak, N., Sytkowski, A. J. (2008). Erythropoietin: new approaches to improved molecular designs and therapeutic alternatives. Curr Pharm Des 14:1302–1310.
  • European Directorate for the Quality of Medicines and HealthCare (2005). European Pharmacopoeia monograph (1316) on erythropoietin concentrated solution, European Pharmacopoeia, 6th ed. (pp 1813–1817 ). Strasbourg, France: Council of Europe.
  • Fisher, J. W. (2003). Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228:1–14.
  • Galloway, S. M. (2000). Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen 35:191–201.
  • ICH (International Conference on Harmonization). (1996). Guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. Fed Reg 61:18198–19202.
  • ICH (International Conference on Harmonization). (1997). A standard battery for genotoxicity testing of pharmaceuticals. Fed Reg 62:62472–62475.
  • Heddle, J. A., Stuart, E., Salamone, M. F. (1984). The bone marrow micronucleus test. In: Kilbey, B. J., Legator, M., Nichols, W., Ramel, C. (Eds.), Handbook of mutagenicity test ­procedures, 2nd ed. (pp 441–457 ). Amsterdam: Elsevier Science Publishers BV.
  • JEMS/MMS (Japanese Environmental Mutagen Society/Mammalian Mutagenicity Study Group). (1988). Atlas of chromosomal aberrations induced by chemicals [Japanese]. Tokyo, Japan: Asakura Publishing Co. Ltd.
  • Kang, K. K., Cho, H., Kim, D. H., Baik, N. G., Kim, W. B. (1998). Mutagenicity study of recombinant human erythropoietin (rhEPO). J Appl Pharmacol 6:56–62.
  • Kirkland, D., Aardema, M., Henderson, L., Muller, L. (2005). Evaluation of the ability of a battery of three in vitro ­genotoxicity tests to discriminate rodent carcinogens and noncarcinogens. I. Sensitivity, specificity, and relative predictivity. Mutat Res 584:1–256.
  • Kirkland, D., Aardema, M., Muller, L., Makoto, H. (2006). Evaluation of the ability of a battery of three in vitro ­genotoxicity tests to discriminate rodent carcinogens and noncarcinogens. II. Further analysis of mammalian cell results, relative predictivity, and tumour profiles. Mutat Res 608:29–42.
  • Kirsch-Volders, M., Aardema, M., Elhajouji, A. (2000). Concepts of threshold in mutagenesis and carcinogenesis. Mutat Res 464:3–11.
  • Lacombe, C., Mayeux, P. (1999). The molecular biology of erythropoietin. Nephrol Dial Transpl 14:22–28.
  • Lovell, D. P., Anderson, D., Albanese, R., Amphlett, G. E., Clare, G., Ferguson, R., et al. (1989). Statistical analysis on in vivo cytogenetic assays. In: Kirkland, D. J. (Ed.), Statistical evaluation of mutagenicity test data (pp 184–232 ). Cambridge, UK: Cambridge University Press.
  • Maron, D.M., Ames, B.N. (1983). Revised methods for the ­salmonella mutagenicity test. Mutat Res 113: 173–215.
  • Muller, L., Kasper, P. (2000). Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutat Res 464:19–34.
  • OECD. (1997). Guideline for the testing of chemicals. TG No. 473. In Vitro mammalian chromosome aberration test. Paris, France: Organization for Economic Cooperation and Development.
  • Pet-Edwards, J. (1989). Risk assessment and decision making using test results: the carcinogenicity prediction and battery selection approach. New York: Plenum Press.
  • Revicki, D. A., Brown, R. E., Henry, D. H., McNeill, M. V., Rios, A., Watson, T. (1994). Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 7:474–484.
  • Richardson, C., Williams, D. A., Allen, J. A., Amphlett, G., Chanter, D. O., Phillips, B. (1989). Analysis of data from in vitro cytogenetics assays. In: Kirkland, D. J. Statistical evaluation of mutagenicity test data (pp 141–154 ). Cambridge, UK: Cambridge University Press.
  • Suzuki, Y., Nagae, Y., Ishikawa, T., Watanabe, Y., Nagashima, T., Matsukubo, K., et al. (1989). Effect of erythropoietin on the micronucleus test. Environ Mol Mutagen 13:314–318.
  • Thybaud, V., Aardema, M., Clements, J., Dearfield, K., Galloway, S., Hayashi, M., et al. (2007). Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Mutat Res 627:41–58.
  • Winearls, C. G., Oliver, D. O., Pippard, M. J., Reid, C., Downing, M. R., Cotes, P. M. (1986). Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients ­maintained by chronic haemodialysis. Lancet 2:1175–1178.
  • Yajima, N., Kurata, Y., Imai, E., Sawai, T., Takeshita, Y. (1993a). Genotoxicity of genetic recombinant human erythropoietin in a novel test system. Mutagenesis 8:231–236.
  • Yajima, N., Kurata, Y., Sawai, T., Takeshita, Y. (1993b). Induction of micronucleated erythrocytes by recombinant human erythropoietin. Mutagenesis 8:221–229.
  • Yajima, N., Kurata, Y., Sawai, T., Takeshita, Y. (1993c). Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoietins. Mutagenesis 8:237–241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.